pharmaceutical investing Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon
pharmaceutical investing Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat
pharmaceutical investing MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma
Krystal Biotech’s KB103 Receives Orphan Medicinal Product Designation in Europe for Dystrophic Epidermolysis Bullosa
pharmaceutical investing Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M
Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for Advanced Parkinson’s Disease
Blue Lagoon Secures $2 Million Line of Credit from Nicola Mining Enhancing Financial Flexibility Ahead of Production
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements
